Zobrazeno 1 - 4
of 4
pro vyhledávání: '"L. A. Emelianova"'
Publikováno v:
Вавиловский журнал генетики и селекции, Vol 23, Iss 3, Pp 256-261 (2019)
Currently, a therapeutic drug based on recombinant antibodies for the prevention and treatment of tick-borne encephalitis virus (TBEV) is developed in ICBFM SB RAS, and the chimeric antibody ch14D5 is considered as one of the key components of this d
Externí odkaz:
https://doaj.org/article/ae03e8ff830048939c1bd3d9622c5ac1
Autor:
G. B. Kaverina, Nina V. Tikunova, S. E. Tkachev, L. A. Emelianova, Ivan K. Baykov, A. L. Matveev
Publikováno v:
Vavilovskij Žurnal Genetiki i Selekcii, Vol 23, Iss 3, Pp 256-261 (2019)
Currently, a therapeutic drug based on recombinant antibodies for the prevention and treatment of tick-borne encephalitis virus (TBEV) is developed in ICBFM SB RAS, and the chimeric antibody ch14D5 is considered as one of the key components of this d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcdcfc30e52780f248f6780ccff68f70
https://vavilov.elpub.ru/jour/article/view/2016
https://vavilov.elpub.ru/jour/article/view/2016
Publikováno v:
Geoecology and Computers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a1589a6ee11d29ff953fe0b3f7679287
https://doi.org/10.1201/9780203753620-46
https://doi.org/10.1201/9780203753620-46
Autor:
L. V. Emelianova, T. I. Filimonovaand
Publikováno v:
History and Computing. 12:347-366
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ccdf5399aa7d21089e63ce90134d7e72
https://doi.org/10.3366/hac.2000.12.3.347
https://doi.org/10.3366/hac.2000.12.3.347